Mineralys Therapeutics
A clinical-stage biopharmaceutical company developing lorundrostat, a selective aldosterone synthase inhibitor, for hypertension and cardio-renal-metabolic diseases.
0 jobs
Jobs
No jobs match — try clearing a filter.
A clinical-stage biopharmaceutical company developing lorundrostat, a selective aldosterone synthase inhibitor, for hypertension and cardio-renal-metabolic diseases.
0 jobs